Unnamed: 0.1 int64 17.5k 26.3k | Unnamed: 0 int64 5 1.8k | pub_date stringlengths 10 10 | headline stringclasses 992
values | trends stringclasses 12
values | close_price float64 12.9 195 | previous_close_price float64 12.9 195 | concatenated_trends stringlengths 18 22 | concatenated_headline stringlengths 141 3k | Company stringclasses 5
values |
|---|---|---|---|---|---|---|---|---|---|
22,926 | 141 | 2010-08-02 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 63.02 | 62.5 | U3, D2, D2, D1, U1 | A Peek Into The Market Before The Trading Starts. Roper Industries Raises Full Year Guidance ( ROP). Roper Industries Posts In-Line Q2 EPS (ROP). Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe e... | ROP |
22,927 | 142 | 2010-08-03 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 63.5 | 63.02 | D2, D2, D1, U1, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,928 | 143 | 2010-08-04 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 63.580002 | 63.5 | D2, D1, U1, U1, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,929 | 144 | 2010-08-05 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 63.43 | 63.580002 | D1, U1, U1, U1, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,930 | 145 | 2010-08-06 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 63.130001 | 63.43 | U1, U1, U1, U1, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,931 | 146 | 2010-08-09 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 63.73 | 63.130001 | U1, U1, U1, D1, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,932 | 147 | 2010-08-10 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D2 | 62.860001 | 63.73 | U1, U1, D1, D1, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,933 | 148 | 2010-08-11 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D4 | 60.5 | 62.860001 | U1, D1, D1, U1, D2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,934 | 149 | 2010-08-12 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 60.150002 | 60.5 | D1, D1, U1, D2, D4 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,935 | 150 | 2010-08-13 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D2 | 59.419998 | 60.150002 | D1, U1, D2, D4, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,936 | 151 | 2010-08-16 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 59.799999 | 59.419998 | U1, D2, D4, D1, D2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,937 | 152 | 2010-08-17 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U2 | 60.970001 | 59.799999 | D2, D4, D1, D2, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,938 | 153 | 2010-08-18 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 60.830002 | 60.970001 | D4, D1, D2, U1, U2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,939 | 154 | 2010-08-19 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D3 | 59.549999 | 60.830002 | D1, D2, U1, U2, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,940 | 155 | 2010-08-20 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 59.459999 | 59.549999 | D2, U1, U2, D1, D3 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,941 | 156 | 2010-08-23 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 59.279999 | 59.459999 | U1, U2, D1, D3, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,942 | 157 | 2010-08-24 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D2 | 58.459999 | 59.279999 | U2, D1, D3, D1, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,943 | 158 | 2010-08-25 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D2 | 57.830002 | 58.459999 | D1, D3, D1, D1, D2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,944 | 159 | 2010-08-26 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 57.869999 | 57.830002 | D3, D1, D1, D2, D2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,945 | 160 | 2010-08-27 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U3 | 59.25 | 57.869999 | D1, D1, D2, D2, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,946 | 161 | 2010-08-30 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D3 | 58.02 | 59.25 | D1, D2, D2, U1, U3 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,947 | 162 | 2010-08-31 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 58.080002 | 58.02 | D2, D2, U1, U3, D3 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,948 | 163 | 2010-09-01 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U4 | 60 | 58.080002 | D2, U1, U3, D3, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,949 | 164 | 2010-09-02 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U2 | 60.849998 | 60 | U1, U3, D3, U1, U4 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,950 | 165 | 2010-09-03 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U2 | 61.959999 | 60.849998 | U3, D3, U1, U4, U2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,951 | 166 | 2010-09-07 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D2 | 61 | 61.959999 | D3, U1, U4, U2, U2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,952 | 167 | 2010-09-08 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U3 | 62.27 | 61 | U1, U4, U2, U2, D2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,953 | 168 | 2010-09-09 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 62.419998 | 62.27 | U4, U2, U2, D2, U3 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,954 | 169 | 2010-09-10 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 62.290001 | 62.419998 | U2, U2, D2, U3, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,955 | 170 | 2010-09-13 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U3 | 64.010002 | 62.290001 | U2, D2, U3, U1, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,956 | 171 | 2010-09-14 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 63.709999 | 64.010002 | D2, U3, U1, D1, U3 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,957 | 172 | 2010-09-15 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 63.880001 | 63.709999 | U3, U1, D1, U3, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,958 | 173 | 2010-09-16 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 63.970001 | 63.880001 | U1, D1, U3, D1, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,959 | 174 | 2010-09-17 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 64.059998 | 63.970001 | D1, U3, D1, U1, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,960 | 175 | 2010-09-20 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U2 | 64.940002 | 64.059998 | U3, D1, U1, U1, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,961 | 176 | 2010-09-21 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 65.300003 | 64.940002 | D1, U1, U1, U1, U2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,962 | 177 | 2010-09-22 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D2 | 64 | 65.300003 | U1, U1, U1, U2, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,963 | 178 | 2010-09-23 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 63.560001 | 64 | U1, U1, U2, U1, D2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,964 | 179 | 2010-09-24 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U3 | 65.339996 | 63.560001 | U1, U2, U1, D2, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,965 | 180 | 2010-09-27 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D2 | 64.57 | 65.339996 | U2, U1, D2, D1, U3 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,966 | 181 | 2010-09-28 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U2 | 65.589996 | 64.57 | U1, D2, D1, U3, D2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,967 | 182 | 2010-09-29 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 65.269997 | 65.589996 | D2, D1, U3, D2, U2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,968 | 183 | 2010-09-30 | Study Finds Clinical Practice Change with Masimo SET Pulse Oximetry Reduces Severe Eye Damage (MASI) | D1 | 65.18 | 65.269997 | D1, U3, D2, U2, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,969 | 184 | 2010-10-01 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U2 | 66.010002 | 65.18 | U3, D2, U2, D1, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,970 | 185 | 2010-10-04 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D2 | 64.980003 | 66.010002 | D2, U2, D1, D1, U2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,971 | 186 | 2010-10-05 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U3 | 66.769997 | 64.980003 | U2, D1, D1, U2, D2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,972 | 187 | 2010-10-06 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 66.949997 | 66.769997 | D1, D1, U2, D2, U3 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,973 | 188 | 2010-10-07 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 66.519997 | 66.949997 | D1, U2, D2, U3, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,974 | 189 | 2010-10-08 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 66.32 | 66.519997 | U2, D2, U3, U1, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,975 | 190 | 2010-10-11 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 66.440002 | 66.32 | D2, U3, U1, D1, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,976 | 191 | 2010-10-12 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 66.199997 | 66.440002 | U3, U1, D1, D1, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,977 | 192 | 2010-10-13 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U2 | 67.330002 | 66.199997 | U1, D1, D1, U1, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,978 | 193 | 2010-10-14 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 66.800003 | 67.330002 | D1, D1, U1, D1, U2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,979 | 194 | 2010-10-15 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 67.050003 | 66.800003 | D1, U1, D1, U2, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,980 | 195 | 2010-10-18 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U2 | 68.07 | 67.050003 | U1, D1, U2, D1, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,981 | 196 | 2010-10-19 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D3 | 66.18 | 68.07 | D1, U2, D1, U1, U2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,982 | 197 | 2010-10-20 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U2 | 67.470001 | 66.18 | U2, D1, U1, U2, D3 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,983 | 198 | 2010-10-21 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U3 | 69.18 | 67.470001 | D1, U1, U2, D3, U2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,984 | 199 | 2010-10-22 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 69.5 | 69.18 | U1, U2, D3, U2, U3 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,985 | 200 | 2010-10-25 | Roper 3Q Beats, Guidance Up - Analyst Blog. Earnings Scheduled For October 25 (LO, CR, TXN, NS, SNV, RSH, AMGN, IVZ, ROP, HRS, MAS, LUX, WRB, PCL) | U2 | 70.379997 | 69.5 | U2, D3, U2, U3, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,986 | 201 | 2010-10-26 | Buy Rating Reiterated on Roper Industries. Roper Industries Positioned To Finish Strong, Oppenheimer Reports | U1 | 70.43 | 70.379997 | D3, U2, U3, U1, U2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,987 | 202 | 2010-10-27 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D2 | 69.360001 | 70.43 | U2, U3, U1, U2, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,988 | 203 | 2010-10-28 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 69.580002 | 69.360001 | U3, U1, U2, U1, D2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,989 | 204 | 2010-10-29 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 69.43 | 69.580002 | U1, U2, U1, D2, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,990 | 205 | 2010-11-01 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 69.760002 | 69.43 | U2, U1, D2, U1, D1 | Buy Rating Reiterated on Roper Industries. Roper Industries Positioned To Finish Strong, Oppenheimer Reports. Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong... | ROP |
22,991 | 206 | 2010-11-02 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 70.43 | 69.760002 | U1, D2, U1, D1, U1 | Buy Rating Reiterated on Roper Industries. Roper Industries Positioned To Finish Strong, Oppenheimer Reports. Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong... | ROP |
22,992 | 207 | 2010-11-03 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 70.260002 | 70.43 | D2, U1, D1, U1, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,993 | 208 | 2010-11-04 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U3 | 72.150002 | 70.260002 | U1, D1, U1, U1, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,994 | 209 | 2010-11-05 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 71.699997 | 72.150002 | D1, U1, U1, D1, U3 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,995 | 210 | 2010-11-08 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 71.389999 | 71.699997 | U1, U1, D1, U3, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,996 | 211 | 2010-11-09 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 71.379997 | 71.389999 | U1, D1, U3, D1, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,997 | 212 | 2010-11-10 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U2 | 72.150002 | 71.379997 | D1, U3, D1, D1, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,998 | 213 | 2010-11-11 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 71.459999 | 72.150002 | U3, D1, D1, D1, U2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
22,999 | 214 | 2010-11-12 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 70.870003 | 71.459999 | D1, D1, D1, U2, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,000 | 215 | 2010-11-15 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 71.419998 | 70.870003 | D1, D1, U2, D1, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,001 | 216 | 2010-11-16 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D3 | 69.790001 | 71.419998 | D1, U2, D1, D1, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,002 | 217 | 2010-11-17 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 70.089996 | 69.790001 | U2, D1, D1, U1, D3 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,003 | 218 | 2010-11-18 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U2 | 71.220001 | 70.089996 | D1, D1, U1, D3, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,004 | 219 | 2010-11-19 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U2 | 72.040001 | 71.220001 | D1, U1, D3, U1, U2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,005 | 220 | 2010-11-22 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 72.150002 | 72.040001 | U1, D3, U1, U2, U2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,006 | 221 | 2010-11-23 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 71.449997 | 72.150002 | D3, U1, U2, U2, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,007 | 222 | 2010-11-24 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U3 | 73.459999 | 71.449997 | U1, U2, U2, U1, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,008 | 223 | 2010-11-26 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 72.769997 | 73.459999 | U2, U2, U1, D1, U3 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,009 | 224 | 2010-11-29 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 72.220001 | 72.769997 | U2, U1, D1, U3, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,010 | 225 | 2010-11-30 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 72.410004 | 72.220001 | U1, D1, U3, D1, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,011 | 226 | 2010-12-01 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U2 | 73.75 | 72.410004 | D1, U3, D1, D1, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,012 | 227 | 2010-12-02 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U2 | 74.809998 | 73.75 | U3, D1, D1, U1, U2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,013 | 228 | 2010-12-03 | "Fast Money" Recap: China Inflation Plays | U1 | 75.290001 | 74.809998 | D1, D1, U1, U2, U2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,014 | 229 | 2010-12-06 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 75.93 | 75.290001 | D1, U1, U2, U2, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,015 | 230 | 2010-12-07 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 76.589996 | 75.93 | U1, U2, U2, U1, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,016 | 231 | 2010-12-08 | Roper Industries Increases Dividend 16% to $.11 | D1 | 76.470001 | 76.589996 | U2, U2, U1, U1, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,017 | 232 | 2010-12-09 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 76.849998 | 76.470001 | U2, U1, U1, U1, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,018 | 233 | 2010-12-10 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U2 | 77.709999 | 76.849998 | U1, U1, U1, D1, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,019 | 234 | 2010-12-13 | 5 Stocks Raising Dividends This Week | D1 | 77.330002 | 77.709999 | U1, U1, D1, U1, U2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,020 | 235 | 2010-12-14 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U1 | 77.370003 | 77.330002 | U1, D1, U1, U2, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,021 | 236 | 2010-12-15 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 77.190002 | 77.370003 | D1, U1, U2, D1, U1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,022 | 237 | 2010-12-16 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | U2 | 78.43 | 77.190002 | U1, U2, D1, U1, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,023 | 238 | 2010-12-17 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D1 | 78.099998 | 78.43 | U2, D1, U1, D1, U2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,024 | 239 | 2010-12-20 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | D2 | 77.129997 | 78.099998 | D1, U1, D1, U2, D1 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
23,025 | 240 | 2010-12-21 | Roper Industries (ROP) exceeded earnings expectations with a strong top line, reporting Q4 EPS of $1.10 versus the expected $0.99. Analysts praised the results, and Citigroup even raised its price target. Roper's strong performance contributed to its inclusion in lists of top-performing stocks. Furthermore, Roper ac... | U1 | 77.860001 | 77.129997 | U1, D1, U2, D1, D2 | Roper Industries (ROP) exceeded Q2 earnings expectations and raised its full-year guidance. A study showed Masimo SET pulse oximetry's positive impact on preventing severe eye damage. Roper Industries' strong third-quarter results and upwardly revised guidance were noted by analysts, with an upcoming earnings report ... | ROP |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.